• ABOUT
  • Company Overview
  • Management
  • Contact Information
• PRODUCTS
  • Product Strategy
  • Product Candidates
  • TRU-015 (Rheumatoid Arthritis)
  • SBI-087 (Rheumatoid Arthritis)
  • SBI-087 (Systemic Lupus Erythematosus)
  • TRU-016 (B-Cell Malignancies)
  • Product Technology
  • SMIP^™ Therapeutics
  • SCORPION^™ Therapeutics
  • TRU-ADhanCe^™ Technology
  • Patient Center
  • Rheumatoid Arthritis (RA)
  • Leukemia
  • Lymphoma
  • Lupus
• PARTNERSHIPS
  • Current Partnerships
• INVESTORS
  • Corporate Governance
  • Stock Information
  • Stock Performance
  • Historic Stock Lookup
  • Investment Calculator
  • Dividend History
  • Analyst Coverage
  • Financials
  • SEC Filings
  • Quarterly Results
  • Annual Reports
  • News & Events
  • Press Releases
  • Events & Presentations
  • Stockholder Services
  • Investor FAQs
  • Contact Us
• MEDIA
• CAREERS
  • Joining the Trubion Team
  • Job Openings
  • Culture and Benefits

Quarterly Results

Print page     Email page

2008

Second Quarter 2008

Trubion Second Quarter 2008 Earnings Conference Call
	Listen to Webcast
Trubion Pharmaceuticals Inc. Reports Second Quarter and First Half 2008 Results
	View Press Release
Form 10-Q
	View SEC Filing

First Quarter 2008

Trubion First Quarter 2008 Earnings Conference Call
	Listen to Webcast
Trubion Pharmaceuticals Inc. Reports First Quarter 2008 Results
	View Press Release
Form 10-Q
	View SEC Filing

2007

Fourth Quarter 2007

Trubion Fourth Quarter 2007 Earnings Conference Call
	Listen to Webcast
Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
	View Press Release
Form 10-K
	View SEC Filing

Copyright 2002–2008 Trubion Pharmaceuticals Inc. All rights reserved.

Site Map | Terms of Use